• ABPI Website
  • Media
  • ABPI response to Clinical Research Implementation Plan publication

ABPI response to Clinical Research Implementation Plan publication

30 June 2022 Posted in News by Press Office

The governments of the four nations of the UK have published a second joint implementation plan for improving clinical research in the UK.

Today’s plan is a positive step towards getting the UK’s clinical research ecosystem back on track. Jennifer Harris, ABPI Director of Research Policy

Welcoming The Future of UK Clinical Research Delivery: 2022 to 2025 implementation plan, Jennifer Harris, Director of Research at the ABPI, said:

“Today’s plan is a positive step towards getting the UK’s clinical research ecosystem back on track.

“Tackling the ongoing challenges created by COVID-19 is a priority for both industry and NHS and is vital if we are to kick-start important research into new medicines and vaccines.

“The ABPI and its members will continue to work closely with all partners involved to help us deliver on the UKs ambition to be the go-to destination for clinical research.”

TAGS
  • Clinical research

Last modified: 20 September 2023

Last reviewed: 20 September 2023

  • This plan has been developed by the cross-sector UK Clinical Research Recovery, Resilience & Growth (RRG) Programme in consultation with stakeholders from across the clinical research ecosystem.
  • Up to £150 million of additional funding from the National Institute for Health and Care Research (NIHR) and £25 million additional funding from RRG Programme delivery partners across the UK announced, in addition to up to £200 million in England for the data for research and development programme announced in March 2022.
  • Plans to embed clinical research in healthcare by using the Health & Care Act’s enhanced research mandate for Integrated Care Systems and embedding research into healthcare organisations’ workforce plans.
  • Further improvements to clinical trial approvals and set-up, including plans for a single UK-wide approval service, new model agreements, and secondary legislation to strengthen the regulatory frameworks for clinical research.
  • Find out more about the UK Clinical Research RRG Programme here.

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

Media enquiries

+44 (0) 20 7747 7147​​